Viyash Scientific Ltd

NSE: VIYASH · BSE: 512529 · Pharmaceuticals & Biotechnology · 46 announcements

Share price: ₹240.77
Market cap: ₹10,633 Cr
Revenue (annual): ₹3,420 Cr
Net profit (annual): ₹177.3 Cr
P/E (TTM): 62.1×Sector 47.3×
Promoter holding: 61.31%+0.00% QoQ
FII holding: 4.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

22 Apr 2026 12:56 IST BSE

Viyash Scientific Board Meeting Outcome

Viyash Scientific Limited appointed Mr. Amit Jain and Mr. Abhiroop Jayanthi as Additional Directors representing the Carlyle Group. The Board also approved a revised ESOP 2026 pool of 1,30,98,000 stock options. These appointments strengthen the company's leadership and strategic ties with Carlyle.

Read the filing ↗